| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 93.12B | 83.62B | 76.94B | 74.53B | 65.27B | 60.87B |
| Gross Profit | 24.19B | 20.98B | 18.08B | 18.39B | 16.13B | 14.37B |
| EBITDA | 16.14B | 12.32B | 10.53B | 10.44B | 9.09B | 8.29B |
| Net Income | 11.17B | 8.48B | 7.23B | 7.32B | 5.99B | 4.97B |
Balance Sheet | ||||||
| Total Assets | 53.49B | 51.76B | 54.04B | 48.88B | 43.48B | 38.89B |
| Cash, Cash Equivalents and Short-Term Investments | 25.21B | 22.83B | 31.36B | 25.27B | 22.06B | 19.31B |
| Total Debt | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B |
| Total Liabilities | 16.12B | 18.81B | 15.44B | 14.23B | 13.30B | 12.89B |
| Stockholders Equity | 36.89B | 32.47B | 38.10B | 34.17B | 29.76B | 25.63B |
Cash Flow | ||||||
| Free Cash Flow | 10.40B | 7.70B | 8.82B | 6.52B | 5.15B | 6.79B |
| Operating Cash Flow | 10.82B | 8.02B | 9.16B | 7.67B | 5.67B | 7.23B |
| Investing Cash Flow | -1.75B | -2.62B | -372.00M | -2.00B | -681.00M | -1.58B |
| Financing Cash Flow | -4.35B | -14.02B | -3.50B | -2.89B | -1.91B | -1.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥73.62B | 7.46 | ― | 3.28% | 5.28% | 28.90% | |
76 Outperform | ¥151.12B | 14.81 | ― | 2.30% | 13.82% | 37.07% | |
75 Outperform | ¥147.46B | 9.34 | 11.52% | 2.76% | 4.00% | 38.72% | |
71 Outperform | ¥21.74B | 11.39 | ― | 1.70% | 22.25% | 31.88% | |
66 Neutral | ¥166.58B | 15.99 | 18.89% | 2.78% | 11.90% | 60.66% | |
65 Neutral | ¥30.65B | 6.28 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |